Post by Chris Ha, DO, RMSK

PRP + shockwave therapy are frequently combined for tendon pathology — yet optimal sequencing remains undefined. For clinicians using ESWT + PRP, how are you timing these therapies in real-world practice? I’m particularly interested in whether your approach is mechanism-driven, evidence-informed, or pragmatic/operational — and whether it varies by tendon or chronicity. Brice Blatz, MD, MS Aneesh Garg, DO, CAQ Adam Tenforde Joshua M. Romero, MD, RMSK Michael Baria, MD MBA Paul Tortland DO, FAOASM, CAQSM, RMSK Dr Don Buford Helen How DO Dr Aston Ngai Ludger Gerdesmeyer Amol Saxena Prof. Dr. Karsten Knobloch, FACS Wolfgang Schaden